Aliquots
-
Immune defenses in asthma
Vanderbilt researchers show that a certain factor negatively impacts the first-line responder cells in the lungs, providing one explanation for why patients with asthma are at greater risk for invasive bacterial disease. Read MoreApr 5, 2016
-
New role identified for p73 gene
The p73 gene is required for the generation of cilia – hair-like projections on cells – findings that could have implications for the study of lung diseases and sterility. Read MoreApr 1, 2016
-
Cancer prevention and poverty
A new epidemiological study supports smoking cessation and avoidance of sedentary lifestyle as cancer prevention measures. Read MoreMar 31, 2016
-
Readmission prediction face-off
Using patients’ health records to assess preparedness for hospital discharge is more effective at predicting readmission or death than commonly used questionnaires. Read MoreMar 23, 2016
-
New treatment for Crohn’s disease
A new biological therapy, ustekinumab, improves markers of disease activity in patients with severe Crohn’s disease. Read MoreMar 22, 2016
-
Putting schizophrenia to bed
A new compound developed at Vanderbilt treats multiple symptoms of schizophrenia in an animal model, without causing sedation. Read MoreMar 21, 2016
-
ROCKs and cancer invasion
The rigidity of the microenvironment around cancer cells drives invasive behavior through distinct ROCK signaling pathways, which could guide the development of specific anti-invasive therapies. Read MoreMar 17, 2016
-
Eye of a cytokine storm
A new animal model can be used to “dissect” the inflammatory response to infection. Read MoreMar 9, 2016
-
Fat hormone’s role in zebrafish
The hormone leptin regulates glucose balance, but not fat stores, in zebrafish. Read MoreMar 8, 2016
-
A clue to cell cleavage
Actin and microtubule cytoskeletons are coordinated during cytokinesis – the process that separates one cell into two and is linked to events underlying cancer. Read MoreMar 7, 2016
-
Melanoma response to immune therapy
Melanoma-specific expression of a certain protein identifies tumors that are more responsive to an immune therapy. Read MoreMar 3, 2016
-
Liver balancing act
Vanderbilt researchers have defined a mechanism that limits liver cell proliferation after injury in order to preserve critical metabolic functions. Read MoreFeb 24, 2016
-
Hypertension hiatus
New findings offer a potential strategy for preventing heritable pulmonary arterial hypertension. Read MoreFeb 23, 2016
-
Face recognition and social anxiety
An inability to recognize faces may be an important mechanism underlying social inhibition and may contribute to, or maintain, social anxiety. Read MoreFeb 19, 2016
-
Combining treatments for melanoma
Combining therapies for melanoma that induce cell senescence and that activate the immune response may improve outcomes for patients. Read MoreFeb 18, 2016
-
Overcoming lung cancer drug resistance
Vanderbilt investigators have discovered a way to overcome the resistance of some lung cancers to certain targeted therapies, which could lead to more effective treatments for lung cancer patients. Read MoreFeb 10, 2016
-
Therapies to prevent preterm birth
Vanderbilt researchers have developed a high-throughput assay that will aid in identifying new compounds to treat preterm labor or postpartum bleeding. Read MoreFeb 9, 2016
-
Building intestinal brush borders
Studies of the molecular complex that helps build specialized cellular surfaces could shed light on the mechanisms underlying a genetic deaf-blindness syndrome accompanied by intestinal disease. Read MoreFeb 8, 2016
-
Dynamics of a drug resistance transporter
Vanderbilt investigators are exploring the shape changes in a multidrug transporter to understand the mechanisms of antibacterial resistance. Read MoreFeb 5, 2016
-
Wound-healing scaffolds
The elasticity of a scaffold used for healing skin wounds is a key factor in promoting regeneration versus scarring. Read MoreJan 27, 2016